Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Spokane
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Spokane, WA

Studies commonly pay $75 to $4,500 per completed study

293 clinical trials are currently recruiting participants within 30 miles of Spokane. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

293studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Spokane right now

Top 25 of 293 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Medical Oncology Associates /ID# 247003 — Spokane, Washington (0.5 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04928846)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
Cancer Care Northwest ( Site 0003) — Spokane, Washington (0.5 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06966700)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Spokane, Washington (0.5 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate Phase 2 Interventional 1,431 participants sought
Principle Research Solutions — Spokane, Washington (0.5 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07415044)

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

Narcolepsy Type 1 Phase 3 Interventional 150 participants sought
Alkermes Investigational Site — Spokane, Washington (0.5 mi) · Sponsor: Alkermes, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07540897)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma Phase 3 Interventional 804 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04423211)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma Phase 3 Interventional 225 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05382338)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Phase 3 Interventional 450 participants sought
Sl0044 50061 — Spokane Valley, Washington (9.0 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT06617325)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Spokane, Washington (0.5 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Lung Non-Small Cell Carcinoma Phase 3 Interventional 336 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07388524)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05008848)

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Heart Failure, Acute Heart Failure Phase 3 Interventional 5,200 participants sought
Spokane, WA Investigative Site 10123 — Spokane, Washington (0.5 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06008197)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Beacon Cancer Care ( Site 0142) — Post Falls, Idaho (22.7 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Breast Cancer, TNBC - Triple-Negative Breast Cancer N/A Observational 900 participants sought
Cancer Care Northwest — Spokane Valley, Washington (9.0 mi) · Sponsor: Tempus AI
See eligibility & contact on ClinicalTrials.gov (NCT07211178)

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Diabetic Nephropathies, Kidney Failure, Chronic Phase 3 Interventional 150 participants sought
Providence Sacred Heart Medical Center — Spokane, Washington (0.5 mi) · Sponsor: Alessandro Doria
See eligibility & contact on ClinicalTrials.gov (NCT06217302)

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Multiple conditions Phase 2 Interventional 120 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06649812)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Psoriatic Arthritis Phase 3 Interventional 1,088 participants sought
Arthritis Northwest, PLLC | Spokane, WA — Spokane, Washington (0.5 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06671483)

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

CLL / SLL, CLL (Chronic Lymphocytic Leukemia) Phase 3 Interventional 306 participants sought
Medical Oncology Associates - Spokane — Spokane, Washington (0.5 mi) · Sponsor: Newave Pharmaceutical Inc
See eligibility & contact on ClinicalTrials.gov (NCT07342478)

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma Phase 2 Interventional 87 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07504588)

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Mitral Valve Regurgitation N/A Interventional 1,056 participants sought
Providence Sacred Heart Medical Center & Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: Medtronic Cardiovascular
See eligibility & contact on ClinicalTrials.gov (NCT03242642)
Actively enrolling

Studies you may be able to join near Spokane

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Spokane

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Inland Northwest Research

★ 5.0
610 S Sherman St Ste 208, Spokane, WA 99202
(509) 960-2818

Premier Clinical Research

★ 5.0
324 S Sherman St, Spokane, WA 99202
(509) 343-3710

Providence Medical Research Center

★ 5.0
105 W 8th Ave Ste 250E, Spokane, WA 99204
(509) 474-4345
"I dont know will see after my appointment today"
— Terry A, 5★

Citta Clinical Research

251 E 5th Ave Ste a, Spokane, WA 99202
(509) 816-1819

Principle Research Solutions

510 S Cowley St, Spokane, WA 99202
(509) 474-1107

WSU Spokane Center for Clinical Research and Simulation (CCRS)

410 North Sherman Street, Spokane, WA 99202
(509) 358-7500

WSU APPL & PRISM Research Clinics

★ 5.0
225 E 3rd Ave, Spokane, WA 99202
(509) 638-2376
"The people who work there are so caring & friendly.<br>I always look forward to visiting them."
— Michael K., 5★

Strategic Research Associates

★ 3.8
29 W Pacific Ave, Spokane, WA 99201
(888) 554-6960
"I have received texts occasionally for the last 10 years that I’m “qualified” for one of their surveys/programs. I’ve filled out 20+ questionnaires t…"
— Morgan Ireland, 1★

Velocity Clinical Research

★ 5.0
9921 N Nevada St Ste 200, Spokane, WA 99218
(509) 505-6227
"The staff is always awesome as well as my experience with the clinical trials. Down 26 pounds in just a few months. Not been this weight since just …"
— Rebecca Williams, 5★

Clinical trials in Spokane: what's recruiting

The Spokane area currently has 293 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Spokane, the most active research areas are:

  • Cancer & Oncology15 studies
  • Immune & Skin3 studies
  • Heart & Vascular2 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Spokane, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Spokane

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Spokane participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Spokane pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Spokane?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Spokane safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Spokane, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Spokane?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Spokane.

Paid clinical trials near Spokane

Other metros within reach

Kennewick, WA54 Nampa, ID261 Boise, ID261 Bellevue, WA1,514 Marysville, WA202 Seattle, WA1,507 Tacoma, WA1,459 Bremerton, WA1,479

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Spokane Bladder Issues Due To Spinal Cord Injury in Spokane All conditions

More of WA

Bellevue1,514 Seattle1,507 Bremerton1,479 Tacoma1,459 Vancouver1,028 Olympia227 Marysville202 Kennewick54

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts